Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

Melatonin may protect hair follicle stem cells from damage caused by chemotherapy.

Scientists created iodinated arylhydantoins and arylthiohydantoins that could potentially be used for imaging prostate cancer. Some versions with specific side-chains showed high potential for this use.

MK-0773 is a moderate inhibitor of the SRD5A2 enzyme.

Certain peptides can prevent hair loss in young rats caused by a cancer drug.

CTP-543 effectively promotes hair regrowth in adults with moderate to severe alopecia areata.

Tofacitinib helped an 8-year-old child recover from a type of hair loss that is hard to treat.

A man developed skin issues from cancer medication, which improved with specific treatments.

Targeting SIRT1 with antisense oligonucleotides could be a promising treatment for hair loss.

Tofacitinib helped a 19-year-old regrow hair after other treatments failed.

SARMs may be an effective treatment for a certain type of breast cancer by blocking cancer growth and spread.

Cepharanthine shows promise as a natural anticancer treatment.

Axitinib treatment turned a man's grey hair back to black.

A new treatment using nanoparticles can effectively prevent and reduce hair loss caused by chemotherapy.

Blocking specific proteins can help remove aging cells and might treat age-related diseases and promote hair growth.

Improving PROTAC delivery systems can enhance their effectiveness and speed up their use in medicine.

Glibenclamide slows breast cancer cell growth by stopping cell division.

SM04755 may be an effective topical treatment for psoriasis.

Cancer prevention has advanced significantly, with some strategies proving successful.

Teicoplanin may help treat hair loss by reducing androgen receptors and boosting hair cell growth.

The treatment showed significant hair regrowth in alopecia areata patients without side effects.

Ruxolitinib helped a woman with a genetic mutation regrow her hair and improved her health.

Oral valganciclovir improved a patient's skin condition caused by immunosuppression.

Sorafenib often causes skin side effects, indicating effective cancer treatment.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

Topical patidegib gel effectively treats basal cell carcinoma in Gorlin syndrome patients without causing the side effects seen with oral treatments.

New treatments for advanced skin cancer are improving patient outcomes, but drug resistance and finding the right treatment combinations are still big challenges.

Topical calcitriol appears safe and may reduce hair loss during chemotherapy.